Filing Details
- Accession Number:
- 0001842952-23-000030
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-02-21 20:05:37
- Reporting Period:
- 2023-02-21
- Accepted Time:
- 2023-02-21 20:05:37
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1842952 | Context Therapeutics Inc. | CNTX | Pharmaceutical Preparations (2834) | 863738787 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1861989 | A. Martin Lehr | 2001 Market Street Suite 3915, Unit #15 Philadelphia PA 19103 | Chief Executive Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2023-02-21 | 5,823 | $0.84 | 159,701 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 820,190 | Indirect | Martin Lehr 2000 Trust |
Footnotes
- The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 15, 2022.
- The price reported above is a weighted average price. These shares were acquired in several transactions at prices ranging from $0.8154 - $0.8470. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and prices at which the transaction was effected.
Billionaire Hedge Funds
